Oncotelic Therapeutcs Inc (OTLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,005 | 8,797 | 7,752 | 4,580 | 4,966 |
| Other current assets | 67 | 129 | 33 | 420 | 142 |
| TOTAL | $7,165 | $9,098 | $8,155 | $5,000 | $5,243 |
| Non-Current Assets | |||||
| PPE Net | 36 | 5 | 8 | 370 | 13 |
| Intangibles | 93 | 118 | 142 | 0 | 191 |
| Other Non-Current Assets | 0 | 0 | 0 | 160 | 0 |
| TOTAL | $129 | $123 | $150 | $530 | $204 |
| Total Assets | $7,294 | $9,221 | $8,305 | $5,180 | $5,447 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 476 | 733 | 430 | 440 | 416 |
| Accrued Expenses | 433 | 202 | 30 | 380 | 181 |
| TOTAL | $1,251 | $1,515 | $891 | $830 | $901 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,251 | $1,515 | $891 | $830 | $901 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,236 | 3,134 | 2,639 | N/A | 2,056 |
| Common Shares | 56 | 30 | 23 | 20 | 17 |
| Retained earnings | -238,508 | -236,411 | -231,447 | -227,310 | -225,432 |
| Other shareholders' equity | 0 | 0 | 0 | -40 | 0 |
| TOTAL | $6,043 | $7,706 | $7,414 | $4,340 | $4,546 |
| Total Liabilities And Equity | $7,294 | $9,221 | $8,305 | $5,170 | $5,447 |